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Background: Atrial fibrillation (AF) is the most common arrhythmia affecting performance in
horses. However, no previous studies have quantified the performance reduction in horses
suffering from AF.
Objectives: To quantify the effect of AF on maximum velocity (Vmax), maximum heart rate (HRmax),
heart rate recovery (T100), hematologic parameters and development of abnormal QRS complexes.
Animals: Nine Standardbred trotters.
Methods: Two-arm controlled trial. Six horses had AF induced by means of a pacemaker and 3
served as sham-operated controls. All horses were subjected to an exercise test to fatigue before
(SET1) and after (SET2) 2 months of AF or sham. The Vmax and HRmax were assessed using a linear
mixed normal model. Abnormal QRS complexes were counted manually on surface ECGs.
Results: Atrial fibrillation resulted in a 1.56 m/sec decrease in Vmax (P< .0001). In the AF group,
HRmax6SD increased from 226611 bpm at SET1 to 311627 bpm at SET 2. The AF group had
higher HRmax at SET2 compared with controls (P< .0001), whereas no difference between the
control and AF groups was observed at SET1 (P5 .96). Several episodes of wide complex tachycar-
dia were observed during exercise in 3 of the AF horses during SET2.
Conclusions and Clinical Importance: Atrial fibrillation resulted in a significant reduction in
performance, an increase in HR and development of abnormal QRS complexes during exercise,
which may be a risk factor for collapse or sudden cardiac death.
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1 | INTRODUCTION
Atrial fibrillation (AF) is a detrimental arrhythmia in horses, and exercise
intolerance is the most common complaint when affected horses are
referred to the veterinarian.1–3 The prevalence of AF in a mixed popu-
lation of horses has been estimated at 0.3% to 2.5%,4–6 but can
increase to 4% in predisposed breeds such as Standardbred trotters.7
Abbreviations: BW, body weight; Ca21, calcium; CI, confidence interval; Cl–,
chloride; ECG, electrocardiogram; HR, heart rate; HRmax, maximum heart rate;
K1, potassium; LAmax, maximum lactate concentration; Na
1, sodium; PP,
plasma protein; SET, standardized exercise test; SR, sinus rhythm; T100, time
in minutes until heart rate reach 100 bpm; VLA4, velocity (m/sec) at lactate
concentration of 4 mmol/L; Vmax, maximum velocity (m/sec); VT, ventricular
tachycardia; V200, velocity (m/sec) at heart rate of 200 bpm.
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The prevalence of AF has been estimated at 5.3% in middle-aged
human athletes,8 and 0.3% in young athletes.9
During AF, no coordinated contraction of the atria occurs, and the
patient must perform without atrial systole contributing to late ventricular
filling.10 However, AF also results in other effects on cardiac hemodynam-
ics, including a decreased end-diastolic pressure and volume in the ven-
tricles, an increase in mean diastolic pressure in the atria and a decreased
interval for passive diastolic filling in the event of tachycardia.10,11 For
horses and humans in sinus rhythm (SR), the active contribution from the
atria can account for approximately 10%-20% of ventricular stroke vol-
ume at rest,12,13 but the absent atrial pumping function in AF patients
rarely clinically affects hemodynamic parameters at rest. However, the
atrial pumping function becomes more important as the intensity of exer-
cise increases, because the relative portion of passive filling is decreased
because of tachycardia.14 A marked decrease in cardiac output therefore
can be expected in AF patients during exercise and tachycardia.15
Previous studies have reported disproportional tachycardia in AF
horses during exercise,3,16,17 and 1 study also reported a broadening of
QRS complexes and abnormal ventricular activation.17 Furthermore, in
horses with AF, increased pulmonary wedge pressure was observed dur-
ing exercise, indicating increased left atrial pressure, most likely as a con-
sequence of absent atrial systolic function.16 To date, no studies have
quantified performance in horses with AF during high-intensity exercise.
The aim of our study therefore was to quantify the effect of AF on
exercise performance and cardiac arrhythmias in Standardbred trotters
during a treadmill exercise test to the point of fatigue, initially when
horses were in SR and after 2 months of induced, chronic AF. We
hypothesized that horses in AF would be unable to reach the same
maximum velocity (Vmax) compared with their own Vmax in SR. Further-
more, we expected that the maximum heart rate (HRmax) would
increase because of AF.
2 | MATERIALS AND METHODS
2.1 | Horses
Nine Standardbred trotter mares (aged 10.464.7 years) were included
in the study, with 3 of the horses serving as sham-operated controls.
The horses all were retired racehorses, and before inclusion, they had
been out of racing and training for a minimum of 2 months. During the
study period, the horses were taken to the paddock daily (except for 3
weeks of box rest after pacemaker implantation), and no other physical
training was allowed except for the treadmill exercise. The study was
approved by the local ethical committee at the Department of
Veterinary Clinical Sciences, University of Copenhagen and The Danish
Animal Experiments Inspectorate (license number 2015-15-0201–
00693) and was performed in accordance with the European Commis-
sion Directive 86/609/EEC.
2.2 | Clinical, cardiac, and lameness examination
The horses underwent a clinical examination including standard hema-
tologic and biochemical blood testing before the study. A lameness
examination (including walking and trotting in a straight line and lung-
ing on hard and soft surfaces) was conducted by 2 experienced veteri-
nary surgeons (see acknowledgments). Based on this examination, a
lameness score was given according to the American Association of
Equine Practitioners lameness grading scale (score 0–5), and horses
only were included in the study if the score was2, which was the
case for all horses. A base-apex 24-hours Holter ECG (KRUTECH Tele-
vet, Kruuse A/S, Maarslev, Denmark) and a standardized echocardio-
graphic examination (2-D, M-mode and color flow Doppler)18 were
conducted using a portable ultrasound unit (Vivid I, GE Healthcare,
Horten, Norway) with a phased array transducer (3S Phased Aray
transducer, GE Healthcare) and a simultaneous ECG recording. All
horses had echocardiographic parameters within the reference interval,
and only trivial valvular regurgitations were found. The clinical and
cardiac examinations were performed by authors RB, HC, and EZH.
2.3 | Pacemaker implantation and induction of AF
Under local anesthesia and sedation, all 9 horses had dual-chamber
pacemakers (Assurity MRI 2272, St Jude Medical Group, St. Paul,
Minnesota) implanted via the right cephalic vein, with 2 leads (Tendril
STS Pacing Leads 100 cm, St Jude Medical Group, St Paul, Minnesota)
fixated (active fixation) in the right atrium to allow for tachypacing as
previously described.19 After 3 weeks of recovery, AF was induced by
intermittent burst pacing (600/min) in runs of 20 s. Once AF was self-
sustained, the pacemaker was programmed to start tachypacing from
both leads (each pacing at a rate of 170/min) if sensing an atrial rate-
<170/min. The next day, burst pacing was initiated again until self-
sustained AF occurred and this approach was continued every day until
AF remained self-sustained. The pacemaker remained off for horses in
the control group. For horses in the AF group, the pacemaker was
turned off permanently when the horses reached self-sustained AF
of>24 hours. The horses subsequently were auscultated daily to
confirm presence of chronic AF.
2.4 | Standardized exercise treadmill test
The horses were weighed on a scale before each exercise test. Rectal
temperature was measured before and immediately after cessation of
each test.
The horses performed 2 standardized exercise tests (SET) on a
high-speed treadmill (Säto, Knivsta, Sweden) at a room temperature of
218C. The first test (SET1) was conducted before implantation of the
pacemakers, and with all horses in SR. The second test (SET2) was
performed 57–58 days after induction of AF for the 6 AF horses. At
this time, the mean duration6 SD of self-sustained AF was 38.5611.9
days (16.2, 36.0, 38.8, 46.1, 46.8, and 47.3 days of AF for each horse,
respectively). The 3 control horses underwent a time-matched experi-
mental protocol without AF induction, and SET2 was performed 57
days after the study start. The week before the first test, all horses
were acclimatized to the treadmill at least 3 times with approximately
10 minutes of walking and trotting each time. The SET consisted of an
incremental test to fatigue, with a warm-up period of 5 minutes of
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walking (1.8–2.0 m/sec) and 5 minutes of trotting (4–5 m/sec) on a
horizontal treadmill. At the end of the warm-up period, the treadmill
was set to a 6% incline. The initial velocity was set to 6.5 m/sec for 6
horses (3 horses from the AF group and 3 control horses). Inadver-
tently, the remaining 3 horses from the AF group had the initial velocity
set to 7 m/sec rather than 6.5 m/sec for both exercise tests. Because
an unpaired t-test showed no significant difference between the num-
ber of steps, maximum heart rate (HR) or maximum lactate concentra-
tion for the 3 AF horses starting at 6.5 m/sec and those starting at
7 m/sec, the 2 groups were merged and the starting velocity was set
to 6.5 m/sec for subsequent analyses for all horses. The velocity was
increased by 0.5 m/sec every minute until the horse reached its limit of
exercise tolerance, which was determined as the inability to maintain
the running speed despite humane encouragement. The horses were
walked for 30 minutes after the test before being returned to the sta-
ble. Two different observers were in charge of the treadmill velocity
and deciding when the horses could not keep pace with the treadmill.
The 2 observers were blinded concerning the maximum velocity (Vmax)
test results of the individual horses from SET1 when performing SET2.
2.5 | Electrocardiographic recording
Electrocardiographic recordings were obtained with a base-apex ECG
(KRUTECH Televet, Kruuse A/S) as previously described.20 Cardiac
arrhythmias and HR were evaluated offline after the SET by an experi-
enced observer using dedicated software (KRUTECH Televet, Kruuse
A/S). The HR was measured at rest, after 10 minutes of warm-up, dur-
ing the last 15 seconds of each exercise step, and finally at 2, 5, 10, 15,
30, 60, and 120 minutes after the exercise test ended. The HR was cal-
culated as a mean of the last 25 beats for each measurement point
(HRmean), and maximum HR was recorded (HRmax) as the mean of the
last 25 beats when horses were running at Vmax. Abnormal QRS com-
plexes were categorized manually. If the QRS complexes had abnormal
morphology or exhibited R-on-T morphology compared with the other
beats, they were categorized as abnormal QRS complexes. If 2 abnor-
mal QRS complexes occurred consecutively, these were categorized as
couplets. If3 occurred, these were categorized as wide complex
tachycardia.21
2.6 | Blood samples
Blood samples were collected before, during and after the exercise test
from a catheter in the jugular vein. Blood samples for measuring potas-
sium (K1), calcium (Ca21), sodium (Na1), chloride (Cl–), lactate, glucose,
and plasma protein (PP) concentrations, packed cell volume (PCV) and
pH were collected in heparinized 3 mL syringes at rest in the stable at
the end of the 10 minutes warm-up period, during the last 15 seconds
of each exercise step, immediately after the test, and at 2, 5, 10, 15,
30, 60, and 120 minutes after the SET ended. When a horse did not
finish the full 60 seconds of the last exercise step, the blood sample
was collected at the point when the horse could no longer keep pace
with the treadmill. All blood samples were chilled and analyzed within
30 minutes using a blood gas analyzer (Radiometer ABL800,
Radiometer, Brønshøj, Denmark). Packed cell volume was measured in
duplicate by centrifuging heparinized blood in a capillary tube using a
microhematocrit reader (Microhematocrit Reader, Hawksley, Colorado),
and PP was measured in duplicate by refractometry (Sur-NE
Refractometer, Atago Inc, Bellevue, Washington).
2.7 | Statistical analysis
Maximum HR (HRmax) during exercise, maximum lactate concentration
(LAmax), and the blood parameters K
1, Ca21, Na1, Cl–, lactate, glucose,
PP, PCV, and pH at the last exercise step were modeled by a linear
mixed normal model including fixed effects of SET, observer and inter-
vention (AF or control group at SET1 or SET2). To account for hetero-
geneity among horses, a random effect of horse was included. The
significance of fixed effects was assessed by F-tests. The maximum
velocity (Vmax), velocity at a HR of 200 bpm (V200), velocity at a lactate
concentration of 4 mmol/L (VLA4) and cardiac recovery time (which
was the time in minutes until HR reached 100 bpm after the exercise
test finished [T100]) were modeled by an interval-grouped normal
model including systematic effects of SET, observer and intervention
(AF or control group at SET1 or SET2). To account for heterogeneity
among horses, inference was performed using a robust independence
working generalized estimating equation procedure. This model specifi-
cation corresponded to an ordinary linear normal model for the actual
values of speed and time, where we accounted for the fact that the
actual values were not observed; rather, we only observed that they
fell within prespecified intervals. The significance of effects was
assessed by robust Wald tests.
Estimated SET-specific intervention effects and changes from
SET1 to SET2 within the AF and control groups were reported with
adjusted P-values and family wise 95% confidence intervals (CI) using
the single-step correction for multiple testing. Goodness-of-fit was vali-
dated both graphically and numerically, assessing systematic departures
in and normality of residuals and random effects estimates.
In all models, independence between residuals and predicted val-
ues was checked by residual plots and normality of residuals, and esti-
mated random effects were checked by qq-plots and by the Shapiro
Wilks test. No indications of model violation were seen in the residual
plots. No substantial deviations from normality were seen in qq-plots.
Data are presented as mean6SD. P-values were evaluated at a
5% significance level. All analyses were performed using the statistical
software R version 3.3.2 (The R Foundation for Statistical Computing,
Vienna, Austria) with the add-on packages lmerTest,22 and multi-
comp.23 Graphs were produced using GraphPad Prism 7.0 (GraphPad
Prism 7.0 software Inc, La Jolla, California).
3 | RESULTS
Body weight (BW) at inclusion in the study was 475647 kg. All horses
gained weight and at the second exercise test, BW was 501644 kg
(P5 .0039). All horses completed both exercise tests. Rectal tempera-
ture for both groups increased after the tests, but we observed no evi-
dence of an effect of intervention on either temperature or weight.
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3.1 | Maximum velocity (Vmax)
The Vmax for the control group at SET1 and SET2 was 10.1060.45 and
10.4260.45 m/sec, respectively. For the AF group, Vmax was 10.336
0.66 and 8.7860.66 m/sec for SET 1 and SET2, respectively. Changes
in the Vmax from SET1 to SET2 were found to be different between the
AF group and the control group (P5 .007). No significant difference
was found between the control and AF groups at SET1 (difference,
0.25 m/sec; CI, 20.61 m/sec; 1.11 m/sec; P5 .76). However, a differ-
ence in the Vmax was observed between the 2 groups at SET2, where
the AF group ran significantly slower compared with the control group
(difference, 20.86 m/sec, CI, 21.17 m/sec; 20.55 m/sec; P< .001). A
significant effect of observer was found for the difference in Vmax
between SET1 and SET2, which was estimated to be 1.17 m/sec higher
when observer 2 was controlling the treadmill velocity (P< .0001). No
systematic effect of observer was found for the remaining parameters.
For the AF group, the observer-adjusted decrease in velocity
from SET 1 to SET 2 was estimated at 1.56 m/sec, (CI, 0.87 m/sec,
2.24 m/sec; P< .0001). For the control group, the observer-adjusted
decrease in velocity from SET 1 to SET 2 was estimated at 0.45 m/sec
(CI,20.33 m/sec, 1.36 m/sec; P5 .31).
3.2 | Maximum HR (HRmax)
Heart rates during the 2 exercise tests are shown for the 2 groups of
horses (Figure 1A,B). The HRmax for the control group at SET1 was
222610 bpm (range, 210–236 bpm), and at SET2, the HRmax was
22369 bpm (range, 215–235 bpm). For the AF group, the HRmax at
SET1 was 226611 bpm (range, 207–242 bpm), and the HRmax at
SET2 was 311627 bpm (range, 276–346 bpm). When measuring only
1 RR interval and finding the shortest during the tests, the maximum
HR for the control group at SET1 was 223615 bpm (range, 210–240
bpm), and at SET2 226611 (range, 218–238). For the AF group, the
individual maximum HR for SET1 was 240631 bpm (range, 210–300)
and during SET2 it was 378626 bpm (range, 337–492 bpm) for the
AF horses. However, only the HRmean was used for the statistical analy-
ses. The change in HRmax from SET1 to SET2 was found to be different
between the 2 groups (P< .001). We found no significant difference
between the control and AF groups at SET1 (difference, 3.50 bpm; CI,
229.3 bpm, 36.3 bpm; P5 .96). However, the AF horses had a higher
HRmax at SET2 compared with the control group (difference, 87 bpm;
CI, 54.2 bpm, 119.8 bpm; P< .0001).
3.3 | Velocity at HR of 200 bpm (V200)
For the control group, the V200 was 8.0360.07 and 7.9260.93 m/sec
at SET1 and SET2, respectively. For the AF group, the V200 was 8.086
0.53 and 5.2160.22 m/sec, respectively (Figure 1A,B).
A significant change in V200 between the 2 groups from SET1 to
SET2 was found (P5 .002). No significant difference was found
between the control and AF groups at SET1 (difference, 0.00 m/sec;
FIGURE 1 Heart rate during the exercise tests and in the recovery period. Mean6SD heart rate for SET1 and SET2 for the control and
AF horses at different treadmill velocities (A and B). Heart rate during the recovery period of up to 120 minutes after cessation of exercise
test is shown in C and D
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CI, 20.56 m/sec, 20.56 m/sec; P51.00). However, at SET2, the AF
horses had a lower V200 compared with the control group (difference,
22.45 m/sec; CI,23.82 m/sec,21.09 m/sec; P< .0001).
3.4 | Heart rate recovery
The HRmean measured during the recovery period is shown in
Figure 1C,D for the control and AF groups. For T100, a significant differ-
ence was found between the 2 groups from SET1 to SET2 (P5 .046).
However, no changes were found when comparing the 2 groups at
SET1 (difference, 24.33 minutes; CI, 219.08 minutes, 10.41 minutes;
P5 .74) and SET2 (difference, 21.69 minutes; CI, 213.42 minutes,
56.80 minutes; P5 .29).
3.5 | Abnormal QRS complexes
Only a few abnormal QRS complexes were observed for the control
group and for SET1 of the AF group (when the horses were in SR).
However, 5 of the 6 horses in SET2 of the AF group showed a high
prevalence of abnormal QRS complexes, and 3 of the horses showed
several episodes of wide complex tachycardia during the exercise tests
(Table 1). Figure 2 gives an example of an exercise ECG from 1 of the
TABLE 1 Prevalence of horses with abnormal QRS complexes during exercise and in the recovery period
Exercise Post exercise (120 min)
SET Rhythm
Single abnormal QRS
complexes Couplets WCT
Single abnormal QRS
complexes Couplets WCT
Control horses 1 SR 0 0 0 1 (0–1) 0 0
2 SR 1 (0–1) 0 0 0 0 0
AF horses 1 SR 1 (0–1) 0 0 2 (0–2) 2 (0–1) 0
2 AF 6 (1–10) 5 (2–12) 3 (5–12) 1 (0–1) 0 0
Abbreviations: AF, atrial fibrillation; Couplets, two consecutive abnormal QRS complexes; WCT, wide complex tachycardia; SET, standardized exercise
test; SR, sinus rhythm.
Number of horses developing abnormal QRS complexes during the exercise test (range specified in brackets).
FIGURE 2 Overview of electrocardiogram (Lead II) from an exercise test. Six-minute continuous ECG (Lead II) from an exercise test (SET2)
in a horse with AF. Arrows point to areas where abnormal QRS complexes are present
BUHL ET AL. Journal of Veterinary Internal Medicine | 51414 BUHL et al.
CI, 20.56 m/sec, 20.56 m/sec; P51.00). However, at SET2, the AF
horses had a lower V200 compared with the control group (difference,
22.45 m/sec; CI,23.82 m/sec,21.09 m/sec; P< .0001).
3.4 | Heart rate recovery
The HRmean measured during the recovery period is shown in
Figure 1C,D for the control and AF groups. For T100, a significant differ-
ence was found between the 2 groups from SET1 to SET2 (P5 .046).
However, no changes were found when comparing the 2 groups at
SET1 (difference, 24.33 minutes; CI, 219.08 minutes, 10.41 minutes;
P5 .74) and SET2 (difference, 21.69 minutes; CI, 213.42 minutes,
56.80 minutes; P5 .29).
3.5 | Abnormal QRS complexes
Only a few abnormal QRS complexes were observed for the control
group and for SET1 of the AF group (when the horses were in SR).
However, 5 of the 6 horses in SET2 of the AF group showed a high
prevalence of abnormal QRS complexes, and 3 of the horses showed
several episodes of wide complex tachycardia during the exercise tests
(Table 1). Figure 2 gives an example of an exercise ECG from 1 of the
TABLE 1 Prevalence of horses with abnormal QRS complexes during exercise and in the recovery period
Exercise Post exercise (120 min)
SET Rhythm
Single abnormal QRS
complexes Couplets WCT
Single abnormal QRS
complexes Couplets WCT
Control horses 1 SR 0 0 0 1 (0–1) 0 0
2 SR 1 (0–1) 0 0 0 0 0
AF horses 1 SR 1 (0–1) 0 0 2 (0–2) 2 (0–1) 0
2 AF 6 (1–10) 5 (2–12) 3 (5–12) 1 (0–1) 0 0
Abbreviations: AF, atrial fibrillation; Couplets, two consecutive abnormal QRS complexes; WCT, wide complex tachycardia; SET, standardized exercise
test; SR, sinus rhythm.
Number of horses developing abnormal QRS complexes during the exercise test (range specified in brackets).
FIGURE 2 Overview of electrocardiogram (Lead II) from an exercise test. Six-minute continuous ECG (Lead II) from an exercise test (SET2)
in a horse with AF. Arrows point to areas where abnormal QRS complexes are present
BUHL ET AL. Journal of Veterinary Internal Medicine | 5
AF horses (SET2). Examples of abnormal QRS complexes with the
R-on-T phenomenon during exercise (including the instantaneous HR)
are shown in Figure 3.
3.6 | Hematological variables
Results of K1, Na1, Cl–, Ca21, lactate, glucose, PCV, PP, and pH for the
time points described above for both the control and AF groups are
shown in Figures S1 and S2 in the Supporting Information. During each
exercise test, K1 increased above the upper limit of the reference inter-
val, whereas Ca21 decreased and Na1 and Cl– increased only slightly.
The blood glucose concentration increased above the reference inter-
val in the post-exercise period, and PCV (and to a lesser extent PP)
increased, whereas pH decreased during the exercise test. A significant
change was found for Na1, Ca21, and PP between the control and AF
groups from SET1 to SET2 (P5 .009, P5 .027, and P5 .031, respec-
tively), but no significant difference was found between the control
and AF groups for SET1 or SET2.
Lactate increased for all groups during each SET, and the concentra-
tions continued to increase for 2–5 minutes after cessation of the exer-
cise test. For the control group, the VLA4 was 7.9260.61 m/sec at SET1
and all 3 results were in the interval 6.50-7.00 m/sec at SET2. For the AF
group, the VLA4 was 8.2560.75 and 7.8060.48 m/sec at SET1 and
SET2, respectively. We found no change in VLA4 between the 2 groups
from SET1 to SET2 (P5 .21), and no significant difference was found
between the control and AF groups at SET1 (difference, 20.33 m/sec;
CI, 20.73 m/sec, 1.40 m/sec; P5 .73). However, the AF horses had
higher VLA4 at SET2 compared with the control group (difference,
0.83 m/sec; CI, 0.39 m/sec, 1.28 m/sec; P< .0001). The maximum lactate
concentration for control horses was 17.662.5 mmol/L for SET1 and
25.368.1 mmol/L for SET2, and for the AF group, LAmax was 19.166.9
and 18.168.4 mmol/L for SET1 and SET2, respectively. No significant
difference was found between the 2 groups at SET2 (P5 .25). Within 2
hours of the exercise test, the lactate concentration was<2 mmol/L for
all but 1 horse, that had a lactate concentration of 2.3 mmol/L.
4 | DISCUSSION
To the best of our knowledge, our study is the first to quantify the
effect of AF on performance in Standardbred trotters during a high-
intensity exercise test. The results confirm that AF is detrimental to
athletic performance, and characterized by decreased velocity, an
increase in HR to an extent far above the normal accepted maximum
HR and decreased V200. In addition, we observed a high prevalence of
abnormal QRS complexes during exercise.
It is well known that horses with AF have a limited capacity for
exercise because of decreased cardiac output secondary to decreased
FIGURE 3 Electrocardiograms (Lead II) showing abnormal QRS complexes with R-on-T phenomenon. A is from a horse during the warm-up
period for SET2; B and C are examples during maximum exercise. Arrows point to abnormal QRS complexes. The instantaneous heart rate
is shown in red
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atrial contraction, tachycardia and irregular rhythm.2,3,16,24 However,
our study has quantified the velocity reduction at approximately 12%,
which is in agreement with a study in human AF patients, which
reported a decrease in exercise capacity of 15% compared with
patients in SR.25
A linear correlation exists between HR during exercise and oxygen
uptake in athletes in SR.26 However, the relationship between HR and
exercise capacity during AF is unclear because of the complex interac-
tion between decreased atrial function, ventricular diastolic filling time
and irregular HR.27 The autonomic nervous system plays a pivotal role
in regulating cardiac rhythm and rate. In horses with structurally normal
hearts, at rest, the dominant parasympathetic tone will prevent the
high number of atrial electrical impulses during AF from being transmit-
ted to the ventricles via the atrioventricular (AV) node by increasing AV
nodal refractoriness. As a result, a normal or slightly increased HR is
present in most horses in AF.28,29 During this period, the bombardment
of the AV node by AF impulses results in concealment of many of
these impulses within the AV node, thereby ensuring a low ventricular
rate.29 During exercise or stress, sympathetic drive dominates, resulting
in a shortening of the AV nodal refractory period, thereby allowing for
increased ventricular stimulation, resulting in an increased ventricular
rate.30 Our study identified an extreme increase in HR in the horses
during exercise. This finding is in agreement with a previous study, in
which a HR of up to 492 bpm was recorded in horses in AF during a
submaximal lunging test.17 A submaximal exercise test performed in
warmblood horses in AF also showed an increased HR compared with
healthy controls,16 but it was not as high as the other reported values17
and our findings.
Estimating HR during AF is challenging because of the high RR var-
iation, typical for this arrhythmia. The RR variation in horses in SR dur-
ing exercise has been estimated at <4%, making an instantaneous HR
calculation based on a single RR interval a valid estimate of HR in
horses with SR.20 To overcome the large RR variation during AF, we
calculated HRmean as a mean of 25 beats, which consequently yielded a
lower HR than if the single shortest RR interval had been measured.
The HR response to exercise in human patients with AF varies among
studies. One study found no significant difference in HR at submaximal
and peak exercise levels between AF and control subjects,25 whereas
other studies report increases in HR during exercise in human patients
with AF as compared with patients with SR.27,31–34 In human patients
with chronic AF, the primary goal of rate-control treatment is to control
the rapid HR response at rest and during exercise, often by beta-
adrenergic blockade, which decreases HR and blood pressure.27,33 In 1
study, the rate control resulted in decreased exercise capacity because
of decreased oxygen uptake,31 whereas another study combining
several HR-reducing medications showed an improvement in exercise
tolerance.35 High HR may be interpreted as a compensatory mecha-
nism for the body to maintain sufficient cardiac output during exercise
because of a lack of atrial contraction caused by AF. However, the
results of our study, showing decreased Vmax and increased VLA4 for
the horses in AF, indicate that the tachycardia does not appear to com-
pensate fully for compromised exercise capacity and is not sufficient to
ensure adequate oxygenation of the body.34 Therefore, there is no
clear conclusion about whether or not high HR is a beneficial adaptive
response to increased physical demands.
The irregular electrical conduction from atria to ventricles as well
as the exceedingly fast ventricular response rate during AF have pro-
found effects on ventricular electrophysiology. Three of the 6 horses
showed a high number of wide complex tachycardias with R-on-T
morphology during exercise, and this high prevalence is in agreement
with a previous study.17 In normal Standardbred trotters, the preva-
lence of single abnormal QRS complexes during racing has been
reported at between 0% and 4%, whereas the prevalence in the imme-
diate period after racing is approximately 20%.36,37 These findings are
in agreement with the results of the exercise tests performed in our
study on horses during SR. The literature includes only limited descrip-
tions of the development of ventricular arrhythmias during exercise in
human AF patients, but some AF patients have exercise-induced ven-
tricular tachycardia, and rate-controlling drugs such as procainamide,
propafenone, and sotalol may decrease the prevalence of premature
ventricular beats.38 Whether this approach could be used in horses
during exercise to decrease ventricular arrhythmias needs to be studied
further.
Defining and detecting the origin of ventricular arrhythmias based
on a 2-lead surface ECG (as used here) is challenging. Supraventricular
beats can have a wide (prolonged, aberrant) QRS morphology at normal
HR, if caused by bundle branch block, or intermittently, if associated
with premature supraventricular beats. In the latter case, widening of
the QRS is caused by partial refractoriness of the ventricular conduc-
tion tissue because of the prematurity of the beat. This type of aber-
rancy may be considered benign, because it disappears when the HR
decreased. Presence of P waves preceding wide-QRS morphology com-
plexes may aid in diagnosing it as supraventricular in origin, as opposed
to ventricular premature beats.39 In ventricular ectopy, the QRS
morphology is abnormal (wide) because of the ventricular origin of the
beats with slow intraventricular conduction. Ventricular ectopy can be
a serious arrhythmia, which, depending on the rate, can cause collapse
or even sudden death because of ventricular tachycardia or ventricular
fibrillation, respectively.
Because of the high HR during exercise, presence of P waves often
cannot be ascertained, thus differentiating wide QRS complex tachy-
cardias as ventricular versus supraventricular in origin may be difficult
or impossible. We were not able to differentiate the 2 conduction pat-
terns in our study, because doing so would require intracardiac His
bundle electrocardiography recordings.40 The treadmill test is consid-
ered a stressful experience for horses, leading to high sympathetic
stimulation, which may explain the HR increase initiated during the
warm-up period, permitting a high number of atrial impulses to be
transmitted through the AV node. The stressful situation may allow for
the aberrant conduction process to predominate. However, higher
sympathetic tone also would enhance automaticity and possibly allow
for more ectopic beats to occur. Consequently, a definite conclusion on
the origin of the abnormal beats in our study cannot be made.
Hematologic and biochemical variables followed a consistent and
repeatable pattern of changes during and after the exercise tests, and
the results generally are in agreement with previous studies conducted
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our study has quantified the velocity reduction at approximately 12%,
which is in agreement with a study in human AF patients, which
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with chronic AF, the primary goal of rate-control treatment is to control
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the horses in AF, indicate that the tachycardia does not appear to com-
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ventricular beats.38 Whether this approach could be used in horses
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further.
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a serious arrhythmia, which, depending on the rate, can cause collapse
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Because of the high HR during exercise, presence of P waves often
cannot be ascertained, thus differentiating wide QRS complex tachy-
cardias as ventricular versus supraventricular in origin may be difficult
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terns in our study, because doing so would require intracardiac His
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ered a stressful experience for horses, leading to high sympathetic
stimulation, which may explain the HR increase initiated during the
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in healthy Thoroughbreds performing a maximum exercise test on a
treadmill.41,42 Although no significant changes could be detected
between SET1 and SET2, lactate seemed to increase for the control
horses in SET2 compared to SET1 (Figure S2A in the Supporting Infor-
mation), which most likely can be explained by the increased velocity
experienced in 2 of the control horses during SET2, when these 2
horses managed to run for 2 minutes longer than in SET1. Maximum
lactate concentration (LAmax) and VLA4 may not be valid markers of
exercise tolerance in AF horses; because it is likely, they will run for a
shorter duration with subsequently decreased lactate production. This
was, however, not confirmed by our results. After exercise, the horses
were walked for 30 minutes and lactate clearance from the blood was
almost completed after 2 hours. This finding is in consistent with a pre-
vious study in racehorses showing fast lactate removal in horses that
are walked after maximal exercise.43 Plasma protein concentration was
lower in the AF group at rest and during and after SET2, compared
with SET1 (Figure S2H in the Supporting Information). In our analysis
of PP at SET2, we observed a significantly lower result in AF horses, a
finding that has not been reported previously in horses. Lower plasma
albumin concentration has been reported in human patients with par-
oxysmal AF,44 whereas another study found the protein serum amyloid
A was increased in AF patients.45 Because individual proteins were not
measured in our study, we cannot differentiate the source of the pro-
tein changes.
A significant effect of observer on treadmill velocity was found,
because 1 observer allowed horses to run faster before fatigue was
determined compared with the other observer. This finding highlights
the subjective definition of fatigue and effect of observer therefore is
relevant to include in the statistical analyses.
All horses gained weight during the study period, which may have
had a detrimental effect on the performance capacity at the second
exercise test. Detraining during the study period also may result in
poorer performance. To minimize the effect of detraining, all horses
recruited had been out of training for at least 2 months before initia-
tion of the trial. Because 2 of our control horses were able to run faster
in the second exercise test compared with the first, we assume that
neither detraining nor weight gain can explain the decreased velocity
observed in the AF horses during their second exercise test. Despite
the horses being untrained, the exercise tolerance parameters V200 and
VLA4 calculated in SR at SET1 were comparable to those of racing
Standardbred mares.46
Although it is uncommon, collapse during exercise has been
reported in horses with AF.47 The high HR and abnormal QRS com-
plexes observed here and supported by results from another study17
lead us to question whether AF horses should be considered safe for
riding purposes. A recently published consensus statement recom-
mends retiring AF horses when their HR exceeds 220 bpm during sus-
tained maximum exercise, or if ventricular arrhythmias are detected
during exercise.21 The recommendations for horses are in agreement
with guidelines for humans, allowing athletes with AF a certain amount
of exercise under strict HR control and in the absence of hemodynamic
impairment, and with the recommendation to stop activity when they
experience palpitations.48 Based on these recommendations, all 6
horses in our study should be considered unsafe for riding purposes.
Future prospective studies looking into the risk of sudden cardiac death
and collapse in horses with spontaneous AF are needed to determine
whether these recommendations are too strict. Additionally, acquiring
intracardiac recordings while AF horses are exercising would help
investigate the origin of the abnormal QRS complexes encountered.
Our findings evidently support the use of exercise ECGs when assess-
ing performance horses with AF.
No race-fit horses were included, and this may be seen as a limita-
tion of our study. In addition, only horses with induced AF were included
and therefore no horses with spontaneous AF were studied. We were
unable to determine whether the induction of AF resulted in myocardial
damage unrelated to AF itself and future studies could address this issue
by performing an additional SET after cardioverting the AF group back
to SR. The sham-operated control group may be underpowered because
of the low number of horses, which may have resulted in a type II error.
Ideally, more horses would have been included.
In conclusion, horses with induced AF showed decreased perform-
ance during a SET to fatigue, as measured by decreased Vmax and V200.
Additionally, a marked increase in HR was observed during exercise,
with HRmax between 276 and 346 bpm. Five of 6 horses in AF showed
a high prevalence of abnormal QRS complexes when exercising, and
several episodes of wide complex tachycardia with R-on-T phenom-
enon were observed in 3 of the horses. We could not determine
whether the abnormal beats were of ventricular origin or if they should
have been characterized as aberrant beats originating from the atria.
No horses collapsed during the tests, but based on the present and
previous studies,16,17 horses with AF should undergo exercise testing
to determine whether or not they should be used for riding purposes.
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